Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study

BACKGROUND: After liver transplantation (LT), nonadherence to immunosuppressants due to the complex regimen can lead to graft rejection and loss. This study assessed the efficacy and safety of conversion from twice-daily tacrolimus (Bid-Tac) to once-daily prolonged-release tacrolimus (OD-Tac) in liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eung Chang, Kim, Seong Hoon, Park, Sang-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248274/
https://www.ncbi.nlm.nih.gov/pubmed/30310047
http://dx.doi.org/10.12659/AOT.910618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248274/
https://www.ncbi.nlm.nih.gov/pubmed/30310047
http://dx.doi.org/10.12659/AOT.910618

Ejemplares similares